Yang et al. have found that inhibition of histone deacetylases by HDAC inhibitors suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression [43]. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.